Intrinsic Value

The intrinsic value of Ceribell Inc (CBLL) under the Base Case is 15.74 USD per share. Compared with the current market price of 26.14 USD, the stock appears Overvalued by 40% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

CBLL Intrinsic Value
$15.74
Overvaluation 40%
Intrinsic Value
Price $26.14
Alert me when CBLL is below its intrinsic value
Today $12.59 · 51.8% below the current price

CBLL is valued in line with its history. A premium of this size has been typical over the past 2 years.

Alternatives to CBLL

Fundamental Analysis

What Ceribell Does

Health Care

CeriBell makes a portable brain-monitoring system used in hospitals to detect seizures and other abnormal brain activity quickly, especially in emergency rooms and intensive care units. Its main product combines a bedside EEG device, disposable headbands with sensors, and software that helps doctors read the signals fast without needing a full traditional EEG setup.

Headquarters
United States of America US
Employees
327
IPO date
Oct 11, 2024
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Ceribell Inc

Efficiency

Earnings Waterfall
Ceribell Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

CBLL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CBLL stock?

The intrinsic value for Ceribell Inc (CBLL) under the Base Case is 15.74 USD.

Is CBLL stock undervalued or overvalued?

Compared with the current market price of 26.14 USD, the stock appears Overvalued by 40% .

Back to Top